Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19

Article

Abstract: Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a recent outbrea

Palabras claves:

Autores:

Caballero A., Calderón N.A., Cepeda M., Diáz Y., Estevez D., Hidalgo C.J., La O Y., Leon K., Lorenzo G., Luaces P.L.o., Martín Y., Mazorra Z., Oyarzábal J.P.A., Pérez Y., Ramos-Suzarte M., Saavedra Hernández D., Santiago W., Tania Crombet, Valenzuela-Silva C.M., Viñet O.

Fuentes:

scopus